LID research on influenza–from seasonal to pandemic, avian to swine–informs public health strategies.
Established in 1942, the Laboratory of Infectious Diseases (LID) has a long history of vaccine development and identification of new agents of viral diseases. LID is noted for undertaking high-risk, high-reward programs that require extraordinary time and resource commitments, such as programs to develop vaccines for viral hepatitis, severe childhood respiratory diseases, and viral gastroenteritis.
Clinical studies complement LID’s major areas of research, including testing candidate vaccines in clinical trials, a human challenge study with influenza to study pathogenesis and immune correlates for protection against the virus, and studies of severe virus infections in persons without known immune deficiency.
Kim Y. Green, Ph.D.
Kanta Subbarao, M.B., B.S., M.P.H.
Patrizia Farci, M.D.
Jeffrey I. Cohen, M.D.
Suzanne U. Emerson, Ph.D.
Alexander G. Pletnev, Ph.D.
Peter L. Collins, Ph.D.
John T. Patton, Ph.D.
Audray K. Harris, Ph.D.
Jeffery K. Taubenberger, M.D., Ph.D.
Last Updated September 20, 2012